Bio-Rad Laboratories share price logo

Bio-Rad Laboratories

NYSE: BIO

Mid Cap

$366.16

-6.02

(-1.62%)

as on

Bio-Rad Laboratories Stock Performance

as on November 3, 2026 at 2:15 pm IST

  • Day's Low

    Day's High

    $361.26
    $376.98
    downward going graph

    1.34%

    Downside

    2.95%

    Upside

    downward going graph
  • 52 Week's Low

    52 Week's High

    $236.73
    $396.23
    downward going graph

    35.35%

    Downside

    8.21%

    Upside

    downward going graph

Bio-Rad Laboratories share price movements today

Previous Close
$372.18
Open
$372.57
Volume
112.6K
Market Cap
$10.0B
Day's Low - High
$361.26 - $376.98
52 Week Low - High
$236.73 - $396.23

Bio-Rad Laboratories Historical Returns

1 Month Return
-0.81 %
3 Month Return
+ 9.4 %
1 Year Return
+ 17.57 %
3 Year Return
+ 27.19 %
5 Year Return
-53.05 %

Bio-Rad Laboratories Stock Fundamentals & Key Indicators

Check Bio-Rad Laboratories market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$10.0B

EPS (TTM)

8.33

Dividend Yield

0.00%

Quarterly Earnings Growth YOY

0.19%

PE Ratio (TTM)

44.68

Industry PE ratio

28.05

PEG Ratio

-0.15

EBITDA

514.7M

Revenue (TTM)

2.6B

Profit Margin

51.90%

Return On Equity TTM

3.15%

Bio-Rad Laboratories vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Bio-Rad Laboratories with its industry peers.

Company
Analyst View
Market Cap
5 Years Return %PE RatioProfit Margin %Dividend Yield %
Buy$10.0B-53.05%44.6851.90%0.00%
StrongBuy$53.0B-20.46%52.8877.98%0.00%
Buy$123.5B-18.06%23.6066.69%2.96%
StrongBuy$183.8B-16.84%39.3357.12%2.37%
StrongBuy$111.9B7.05%30.8865.52%1.21%

Stock Returns calculator for Bio-Rad Laboratories Stock including INR - Dollar returns

The Bio-Rad Laboratories stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Impact: The bonus return you make when the US Dollar rises against the Rupee; calculated on the full amount you walk away with, not just what you invested in.

Investment Value

₹1,00,000

  • 1Y

  • 3Y

  • 5Y

  • 7Y

  • 10Y

Bio-Rad Laboratories investment value today

Current value as on today

₹1,25,759

Returns

₹25,759

(+25.76%)

Returns from Bio-Rad Laboratories Stock

₹17,574 (+17.57%)

Dollar Impact

₹8,185 (+8.18%)

Analyst Recommendation on Bio-Rad Laboratories Stock

Based on 1 analysts

BUY

100.00%

Buy

0.00%

Hold

0.00%

Sell

Based on 1 analysts, 100% of analysts recommend a 'BUY' rating for Bio-Rad Laboratories. Average target price of $335

Bio-Rad Laboratories Share Price Target

Get share price movements and forecasts by analysts on Bio-Rad Laboratories.

What analysts predicted

-9.3%DOWNSIDE

Target Price

$335

Current Price

$366.16

Analyzed by

1 Analysts

High

$390

Target

$335.00

Low

$390

Bio-Rad Laboratories target price $335, a slight downside of -9.3% compared to current price of $366.16. According to 1 analysts rating.

Indian Investors' Interest in Bio-Rad Laboratories Stock

Search interest for Bio-Rad Laboratories Stock has increased by 39% in the last 30 days, reflecting an upward trend in search activity.

Time period: to

Change:39% versus previous 30 day period

Bio-Rad Laboratories Quarterly Profit & Loss

All numbers in Millions USD

Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Total Revenue
610
638
649
667
585
651
653
693
592
651
Gross Profit
326
355
355
341
306
345
343
345
309
345
Operating Income
52
101
64
58
23
77
66
61
34
72
EBITDA
540
-2,737
912
-847
133
467
-374
983
-636
542
Interest Expense
12
12
12
12
12
12
12
12
12
-
Depreciation
37
36
38
49
38
40
44
42
40
-
Income Before Tax
491
-2,786
861
-908
83
414
-431
929
-689
542
Income Tax Expense
107
-620
208
-193
19
96
-89
209
-162
170
Net Income
383
-2,165
653
-715
64
317
-341
720
-527
371
Net Profit Margin
53.45%
55.62%
54.78%
51.22%
52.27%
52.99%
52.59%
49.80%
52.25%
53.12%

Bio-Rad Laboratories Annual Profit & Loss

All numbers in Millions USD

Dec 2017
Dec 2018
Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Dec 2025
Total Revenue
2,160
2,290
2,311
2,545
2,922
2,802
2,671
2,566
2,583
Gross Profit
1,187
1,224
1,256
1,437
1,638
1,567
1,426
1,378
1,343
Operating Income
116
-108
229
421
500
482
337
269
270
EBITDA
269
674
2,418
5,078
5,588
-4,528
-654
-2,142
1,209
Interest Expense
23
23
23
21
1
38
49
48
49
Depreciation
148
138
134
138
137
137
145
151
165
Income Before Tax
97
507
2,261
4,918
5,449
-4,704
-850
-2,342
995
Income Tax Expense
-16
146
502
1,103
1,194
-1,076
-212
-498
235
Net Income
114
360
1,758
3,814
4,254
-3,627
-637
-1,844
759
Net Profit Margin
54.97%
53.46%
54.38%
56.48%
56.05%
55.93%
53.42%
53.73%
52.01%

Bio-Rad Laboratories Quarterly Cash Flow

All numbers in Millions USD

Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Net Income
383
-2,165
653
-715
64
-120
-341
720
-527
-13
Operating Cash Flow
69
97
163
124
129
116
120
164
108
98
Investing Cash Flow
-43
-30
-55
-30
2
-115
-43
-34
-93
-66
Financing Cash Flow
0
-96
-95
-26
-97
-136
-52
3
-44
-27
Change in Cash
29
-26
4
77
33
-151
26
131
-23
9

Bio-Rad Laboratories Annual Cash Flow

All numbers in Millions USD

Dec 2017
Dec 2018
Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Dec 2025
Net Income
122
365
1,758
3,814
4,254
-3,627
-637
-1,844
759
Operating Cash Flow
104
285
457
584
669
194
374
455
532
Investing Cash Flow
-175
-186
-208
-69
-797
-1,207
20
-160
-189
Financing Cash Flow
0
-48
-22
-523
-55
973
-425
-218
-283
Change in Cash
-72
49
228
4
-195
-36
-30
85
40

Global Institutional Holdings in Bio-Rad Laboratories

Check out the Institutions with significant holdings in Bio-Rad Laboratories.

Funds
Holdings
Norman Schwartz
37.33%
Jean Marie Eveillard
12.02%
First Eagle Funds
9.02%
BlackRock, Inc.
7.84%
Vanguard
7.46%

Bio-Rad Laboratories News & Key Events

  • img

    Today's Timeline - 27 October

    Tue, 08:28 PM

    -

    Elliott Investment Management builds a large position in Bio-Rad, citing undervaluation and potential for capital return.

    Wed, 02:27 AM

    -

    Bio-Rad COO acquires 1,869 shares as stock awards vest, increasing his stake in the company.

Insights on Bio-Rad Laboratories

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgPOSITIVE IMPACT

    Profit Spike

    img

    Netprofit is up for the last 2 quarters, -527.10M → 371.40M (in $), with an average increase of 241.9% per quarter

  • imgPOSITIVE IMPACT

    Price Rise

    img

    In the last 6 months, BIO stock has moved up by 42.7%

  • imgPOSITIVE IMPACT

    Revenue Rich

    img

    Revenue is up for the last 2 quarters, 592.09M → 650.99M (in $), with an average increase of 9.1% per quarter

  • imgPOSITIVE IMPACT

    Best in 1 Year

    img

    In the last 1 year, BIO has outperformed top 5 stocks with highest market-cap in its industry

  • imgNO EFFECT

    Against Peers

    img

    In the last 3 years, Edwards Lifesciences Corp has given 39.0% return, outperforming this stock by 11.8%

About Bio-Rad Laboratories

Bio-Rad Laboratories, Inc., established in 1952 and headquartered in Hercules, California, operates as a global provider of life science research and clinical diagnostic products. Its operations span across the United States, Canada, Europe, Asia, and Latin America. The company is organized into two primary divisions: Life Science and Clinical Diagnostics. The Life Science division is responsible for developing, manufacturing, and commercializing a diverse array of reagents, equipment, and laboratory instruments. These products are crucial for various research methodologies, biopharmaceutical manufacturing processes, and food quality testing. This segment focuses on specialized areas within the life sciences, including proteomics, genomics, biopharmaceutical production, cellular biology, and food safety. Its clientele encompasses academic institutions (such as universities and medical schools), industrial research organizations, government agencies, pharmaceutical companies, biotechnology firms, food producers, and food testing laboratories. In contrast, the Clinical Diagnostics division designs, produces, sells, and supports a comprehensive suite of test systems, informatics solutions, diagnostic kits, and specialized quality control products for clinical laboratories. This segment provides reagents, instruments, and software specifically tailored for particular niches within the in vitro diagnostics market. Its customer base includes reference laboratories, hospital laboratories, state newborn screening facilities, physicians' office laboratories, and transfusion laboratories. Beyond these core segments, Bio-Rad also offers systems and products designed to separate complex chemical and biological materials, as well as to identify, analyze, and purify their individual components. The company distributes its extensive product portfolio through a combination of its direct sales force and a network of third-party distributors, agents, brokers, and resellers.
OrganisationBio-Rad Laboratories
Headquarters1000 Alfred Nobel Drive, Hercules, CA, 94547, US
IndustryMedical - Devices
CEONorman D. Schwartz

Key Management of Bio-Rad Laboratories

Name

Title

Mr. Norman D. Schwartz

Chairman & CEO

Mr. James J. Barry

Executive VP & President of Life Science Group

Mr. Rajat Mehta

Executive Vice President of Global Commercial Operations

Mr. Ruben Argueta

Vice President of Investor Relations

Matthew Werner

Senior VP and Chief Compliance & Privacy Officer

Mr. Jonathan P. DiVincenzo

President & COO

Mr. Roop K. Lakkaraju CPA

Executive VP & CFO

Ms. Courtney C. Enloe

Executive VP, General Counsel & Secretary

Ms. Nanditha R. Yelamanchi

Executive Vice President of Global Human Resources

Mr. Michael Crowley

Executive Vice President of Global Commercial Operations

FAQs

What is Bio-Rad Laboratories share price today?

Bio-Rad Laboratories share price today is $366.16 as on at the close of the market. Bio-Rad Laboratories share today touched a day high of $376.98 and a low of $361.26.

What is the 52 week high and 52 week low for Bio-Rad Laboratories share?

Bio-Rad Laboratories share touched a 52 week high of $396.23 on and a 52 week low of $236.73 on . Bio-Rad Laboratories stock price today i.e. is closed at $366.16,which is 7.59% down from its 52 week high and 54.67% up from its 52 week low.

What is Bio-Rad Laboratories's market capitalisation today?

Bio-Rad Laboratories market capitalisation is $0.01T as on .

How to invest in Bio-Rad Laboratories Stock (BIO) from India?

  1. Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
  2. Step 2: Search for Bio-Rad Laboratories on INDmoney app. Click on Buy button.

What is the minimum amount required to buy Bio-Rad Laboratories Stock (BIO) from India?

Indian investors can start investing in Bio-Rad Laboratories (BIO) shares with as little as ₹94.9000015258789 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹949.00 in Bio-Rad Laboratories stock (as per the Rupee-Dollar exchange rate as on ). Based on Bio-Rad Laboratories share’s latest price of $366.16 as on November 3, 2026 at 8:45 am IST, you will get 0.0273 shares of Bio-Rad Laboratories. Learn more about fractional shares .

What are the returns that Bio-Rad Laboratories has given to Indian investors in the last 5 years?

Bio-Rad Laboratories stock has given -53.05% share price returns and 27.07% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?